Related Experiment Videos
[Aspergillosis and sarcoidosis]
S Lachkar1, S Dominique, L Thiberville
1Service de Pneumologie, CHU Charles Nicolle, Rouen, France.
Introduction:
Diffuse fibrosing sarcoidosis represents an important predisposing factor for infection by Aspergillus sp. The clinical features and specific complications are illustrated by 3 case reports.
Background:
Patients with chronic fibrosing sarcoidosis and cystic changes or cavitation in the upper lobes are the most prone to aspergillosis. Aspergilloma is the most common form and can be difficult to distinguish from chronic necrotising aspergillosis. Sarcoidosis with aspergillosis is associated with an increased incidence of respiratory failure and fatal haemoptysis. The 3 cases presented in this paper also illustrate the poor efficacy of oral antifungal drugs and bronchial embolisation. Surgery is often necessary but may be difficult on account of the extent of the lesions and poor respiratory function.
Viewpoint:
In the future the use of new drugs such as voriconazole and posaconazole may improve the prognosis of this complication.
Conclusion:
Aspergillosis represents a frequent complication of diffuse fibrosing sarcoidosis which warrants early detection and treatment on account of its poor prognosis.
Insights
Diffuse fibrosing sarcoidosis increases the risk of aspergillosis, a serious fungal infection. Early detection and treatment are crucial due to the poor prognosis associated with this complication.
Area of Science:
- Pulmonology
- Infectious Diseases
- Mycology
Background:
- Diffuse fibrosing sarcoidosis is a significant risk factor for Aspergillus sp. infection.
- Patients with chronic fibrosing sarcoidosis, particularly with cystic changes or cavitation in upper lobes, are most susceptible to aspergillosis.
Observation:
- Aspergilloma is the most common form, often challenging to differentiate from chronic necrotizing aspergillosis.
- Sarcoidosis-associated aspergillosis is linked to a higher incidence of respiratory failure and fatal hemoptysis.
Findings:
- Oral antifungal drugs and bronchial embolization show limited efficacy in treating sarcoidosis with aspergillosis.
- Surgical intervention is frequently required but complicated by extensive lesions and compromised respiratory function.
Implications:
- Newer antifungal agents like voriconazole and posaconazole may offer improved treatment outcomes.
- Prompt diagnosis and management of aspergillosis in sarcoidosis patients are essential for improving prognosis.
Related Concept Videos
Rocky Mountain Spotted Fever
Atypical Pneumonia
Other Pulmonary Disorders
Toxoplasmosis
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Rheumatic Heart Disease I: Introduction